Name: Formulating Poorly Water Soluble Drugs (en Inglés)
Price: 810.56 PEN
Availability: InStock
Author: Williams III, Robert O. ; Davis Jr, Daniel A. ; Miller, Dave A.
ISBN: 9783030887186

portada Formulating Poorly Water Soluble Drugs (en Inglés)

Formulating Poorly Water Soluble Drugs (en Inglés)

Formato

Libro Físico

Editorial

Springer

Autor

Williams III, Robert O. ; Davis Jr, Daniel A. ; Miller, Dave A.

Idioma

Inglés

N° páginas

693

Encuadernación

Tapa Dura

Dimensiones

25.4 x 17.8 x 3.8 cm

Peso

1.43 kg.

ISBN13

9783030887186

N° edición

0003

Categorías

Medicina preclínica: ciencias básicas
Farmacología
Farmacia/prescripción/dispensación

Formulating Poorly Water Soluble Drugs (en Inglés)

Williams Iii, Robert O. ; Davis Jr, Daniel A. ; Miller, Dave A. (Autor) · Springer · Tapa Dura

Libro Nuevo Importado

Envío: 12 a 17 días háb.

S/ 1.801,24S/ 810,56

-55%

Costos de importación incluídos en el precio ✅

Libro Nuevo

Quedan más de 100 unidades

S/ 810,56

Llega entre el 06 Jul y el 14 Jul a CERCADO DE LIMA, Lima. Seleccionar ubicación

Agregar a lista de deseos

Reseña del libro "Formulating Poorly Water Soluble Drugs (en Inglés)"

The objective of this third edition is to consolidate within a single text the most current knowledge, practical methods, and regulatory considerations pertaining to formulations development with poorly water-soluble molecules. A pharmaceutical scientist's approach toward solubility enhancement of a poorly water-soluble molecule typically includes detailed characterization of the compound's physiochemical properties, solid-state modifications, advanced formulation design, non-conventional process technologies, advanced analytical characterization, and specialized product performance analysis techniques. The scientist must also be aware of the unique regulatory considerations pertaining to the non-conventional approaches often utilized for poorly water-soluble drugs. One faced with the challenge of developing a drug product from a poorly soluble compound must possess at a minimum a working knowledge of each of the above mentioned facetsand detailed knowledge of most. In light of the magnitude of the growing solubility problem to drug development, this is a significant burden especially when considering that knowledge in most of these areas is relatively new and continues to develop.